PLASMA PREKALLIKREIN, COAGULATION AND FIBRINOLYTIC PARAMETERS IN MYELOMA PATIENTS

dc.creatorANNICHINOBIZZACCHI, JM
dc.creatorSAMPAIO, CAM
dc.date1992
dc.dateMAY
dc.date2014-07-30T14:32:17Z
dc.date2015-11-26T17:42:59Z
dc.date2014-07-30T14:32:17Z
dc.date2015-11-26T17:42:59Z
dc.date.accessioned2018-03-29T00:24:59Z
dc.date.available2018-03-29T00:24:59Z
dc.identifierNouvelle Revue Francaise D Hematologie. Springer Verlag, v. 34, n. 2, n. 201, n. 203, 1992.
dc.identifier0029-4810
dc.identifierWOS:A1992JB83300009
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/59908
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/59908
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1287458
dc.descriptionPlasmatic prekallikrein, factor XII, factor XI, C1-inactivator and alpha(2)-macroglobulin were evaluated in myeloma patients. Results suggest no modification in the contact phase since there was no significant difference between patients and controls. Other parameters of blood coagulation and fibrinolysis (APTT, TT, fibrinogen, factor V, ELT and LAFP) gave findings consistent with those described in the literature.
dc.description34
dc.description2
dc.description201
dc.description203
dc.languageen
dc.publisherSpringer Verlag
dc.publisherNew York
dc.relationNouvelle Revue Francaise D Hematologie
dc.relationNouv. Rev. Fr. Hematol.
dc.rightsfechado
dc.rightshttp://www.springer.com/open+access/authors+rights?SGWID=0-176704-12-683201-0
dc.sourceWeb of Science
dc.subjectMULTIPLE MYELOMA
dc.subjectPLASMATIC PREKALLIKREIN
dc.subjectCOAGULATION
dc.subjectDysproteinemias
dc.titlePLASMA PREKALLIKREIN, COAGULATION AND FIBRINOLYTIC PARAMETERS IN MYELOMA PATIENTS
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución